Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-25-125526
Filing Date
2025-12-29
Accepted
2025-12-23 21:27:03
Documents
16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0270736-s1_cadrenal.htm S-1 284331
2 OPINION OF BLANK ROME LLP ea027073601ex5-1_cadrenal.htm EX-5.1 7328
3 CONSENT OF WITHUMSMITH+BROWN, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR ea027073601ex23-1_cadrenal.htm EX-23.1 2230
4 FILING FEE TABLE ea027073601ex-fee_cadrenal.htm   iXBRL EX-FILING FEES 13785
5 GRAPHIC image_001.jpg GRAPHIC 4687
6 GRAPHIC ex5-1_001.jpg GRAPHIC 2511
  Complete submission text file 0001213900-25-125526.txt   441117

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ea027073601ex-fee_cadrenal_htm.xml XML 4958
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-292444 | Film No.: 251602245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)